Puma Biotechnology, Inc.

NasdaqGS:PBYI 株式レポート

時価総額:US$142.4m

Puma Biotechnology マネジメント

マネジメント 基準チェック /34

Puma Biotechnologyの CEO はAlan Auerbachで、 Sep2010年に任命され、 の在任期間は 14.17年です。 の年間総報酬は$ 2.94Mで、 29.8%給与と70.2%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の14.04%を直接所有しており、その価値は$ 19.99M 。経営陣と取締役会の平均在任期間はそれぞれ6.8年と8年です。

主要情報

Alan Auerbach

最高経営責任者

US$2.9m

報酬総額

CEO給与比率29.8%
CEO在任期間14.2yrs
CEOの所有権14.0%
経営陣の平均在職期間6.8yrs
取締役会の平均在任期間8yrs

経営陣の近況

Recent updates

Puma Biotechnology's (NASDAQ:PBYI) Performance Is Even Better Than Its Earnings Suggest

Nov 14
Puma Biotechnology's (NASDAQ:PBYI) Performance Is Even Better Than Its Earnings Suggest

Is Puma Biotechnology (NASDAQ:PBYI) A Risky Investment?

Sep 07
Is Puma Biotechnology (NASDAQ:PBYI) A Risky Investment?

Lacklustre Performance Is Driving Puma Biotechnology, Inc.'s (NASDAQ:PBYI) 26% Price Drop

Aug 15
Lacklustre Performance Is Driving Puma Biotechnology, Inc.'s (NASDAQ:PBYI) 26% Price Drop

The Market Doesn't Like What It Sees From Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Earnings Yet As Shares Tumble 25%

Jun 07
The Market Doesn't Like What It Sees From Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Earnings Yet As Shares Tumble 25%

Here's Why We Think Puma Biotechnology (NASDAQ:PBYI) Might Deserve Your Attention Today

Jun 05
Here's Why We Think Puma Biotechnology (NASDAQ:PBYI) Might Deserve Your Attention Today

We Like The Quality Of Puma Biotechnology's (NASDAQ:PBYI) Earnings

May 09
We Like The Quality Of Puma Biotechnology's (NASDAQ:PBYI) Earnings

Puma Biotechnology: A Story In Flux Heading Into Mid-2024

May 05

Is There An Opportunity With Puma Biotechnology, Inc.'s (NASDAQ:PBYI) 46% Undervaluation?

Apr 10
Is There An Opportunity With Puma Biotechnology, Inc.'s (NASDAQ:PBYI) 46% Undervaluation?

There's Reason For Concern Over Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Massive 31% Price Jump

Mar 01
There's Reason For Concern Over Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Massive 31% Price Jump

Here's Why Puma Biotechnology (NASDAQ:PBYI) Has A Meaningful Debt Burden

Dec 27
Here's Why Puma Biotechnology (NASDAQ:PBYI) Has A Meaningful Debt Burden

Puma Biotechnology (NASDAQ:PBYI) Has A Somewhat Strained Balance Sheet

Sep 08
Puma Biotechnology (NASDAQ:PBYI) Has A Somewhat Strained Balance Sheet

Puma Biotechnology, Inc. (NASDAQ:PBYI) Held Back By Insufficient Growth Even After Shares Climb 34%

Apr 17
Puma Biotechnology, Inc. (NASDAQ:PBYI) Held Back By Insufficient Growth Even After Shares Climb 34%

We Think Puma Biotechnology (NASDAQ:PBYI) Can Stay On Top Of Its Debt

Dec 14
We Think Puma Biotechnology (NASDAQ:PBYI) Can Stay On Top Of Its Debt

Puma Biotechnology, Takeda enter licensing agreement for cancer treatment alisertib

Sep 20

Puma Biotechnology (NASDAQ:PBYI) Takes On Some Risk With Its Use Of Debt

Sep 05
Puma Biotechnology (NASDAQ:PBYI) Takes On Some Risk With Its Use Of Debt

CEO報酬分析

Puma Biotechnology の収益と比較して、Alan Auerbach の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

US$23m

Jun 30 2024n/an/a

US$9m

Mar 31 2024n/an/a

US$15m

Dec 31 2023US$3mUS$878k

US$22m

Sep 30 2023n/an/a

US$4m

Jun 30 2023n/an/a

-US$2m

Mar 31 2023n/an/a

US$5m

Dec 31 2022US$3mUS$852k

US$2k

Sep 30 2022n/an/a

US$10m

Jun 30 2022n/an/a

-US$34m

Mar 31 2022n/an/a

-US$49m

Dec 31 2021US$18mUS$827k

-US$29m

Sep 30 2021n/an/a

-US$48m

Jun 30 2021n/an/a

-US$35m

Mar 31 2021n/an/a

-US$27m

Dec 31 2020US$4mUS$834k

-US$60m

Sep 30 2020n/an/a

-US$56m

Jun 30 2020n/an/a

-US$42m

Mar 31 2020n/an/a

-US$82m

Dec 31 2019US$4mUS$780k

-US$76m

Sep 30 2019n/an/a

-US$95m

Jun 30 2019n/an/a

-US$92m

Mar 31 2019n/an/a

-US$99m

Dec 31 2018US$6mUS$757k

-US$114m

Sep 30 2018n/an/a

-US$147m

Jun 30 2018n/an/a

-US$210m

Mar 31 2018n/an/a

-US$243m

Dec 31 2017US$3mUS$733k

-US$292m

報酬と市場: Alanの 総報酬 ($USD 2.94M ) は、 US市場 ($USD 652.28K ) の同規模の企業の平均を上回っています。

報酬と収益: Alanの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Alan Auerbach (54 yo)

14.2yrs

在職期間

US$2,944,748

報酬

Mr. Alan H. Auerbach is the Founder of Puma Biotechnology, Inc. and has been its Executive Chairman since October 4, 2011 and serves as its Chief Executive Officer, President and Secretary since September...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Alan Auerbach
Founder14.2yrsUS$2.94m14.04%
$ 20.0m
Maximo Nougues
CFO & Principal Accounting Officer6yrsUS$1.23m0.24%
$ 334.6k
Douglas Hunt
Chief Regulatory Affairs6.8yrsUS$1.02m0.19%
$ 269.0k
Jeffrey Ludwig
Chief Commercial Officer4.7yrsUS$1.38m0.17%
$ 235.9k
Mariann Ohanesian
Senior Director of Investor Relations13yrsデータなしデータなし

6.8yrs

平均在職期間

56.5yo

平均年齢

経験豊富な経営陣: PBYIの経営陣は経験豊富で経験豊富です(平均在職期間は6.8年)。


取締役

名称ポジション在職期間報酬所有権
Alan Auerbach
Founder13.1yrsUS$2.94m14.04%
$ 20.0m
Jay Moyes
Lead Independent Director12.6yrsUS$172.27k0.043%
$ 61.8k
Michael Miller
Independent Director6.8yrsUS$162.90k0.041%
$ 58.0k
Troy Wilson
Independent Director11.1yrsUS$172.27k0.0018%
$ 2.6k
Alessandra Cesano
Independent Director2.3yrsUS$152.27k0.055%
$ 78.3k
Adrian Senderowicz
Independent Director9.3yrsUS$164.77k0%
$ 0
Allison Dorval
Independent Director3.3yrsUS$154.77k0.067%
$ 95.7k
Brian Stuglik
Independent Director4.3yrsUS$161.65k0.10%
$ 142.3k

8.0yrs

平均在職期間

62yo

平均年齢

経験豊富なボード: PBYIの 取締役会経験豊富 であると考えられます ( 8年の平均在任期間)。